New Low-Cost Ligand™ Catalogue Launched -- High Quality Ligands at Affordable Prices

Share Article

Ascent Scientific (http://www.ascentscientific.com) announced the launch of the new Low-Cost Ligand™ catalogue. The Autumn 2008 catalogue has almost doubled in size, with new products for glutamate, signalling, ion channel and peptide receptor research.

I would like to extend a big thank-you to everyone who has suggested a product -- and please keep your suggestions coming -- we will continue to add them to our range!

Weston-Super-Mare, UK Ascent Scientific has introduced essential and novel research tools such as the mGlu7 antagonist MMPIP, and the group II agonist LY 354740. Signalling tools include the ALK inhibitor SB 431542 and the commonly used MEK1 inhibitor PD98059.

Steve Roome, Commercial Director announced, "Since the launch of our last catalogue we have almost doubled our number of products, thanks to numerous requests and suggestions from researchers. We now offer a wider range of agonists, antagonists and inhibitors, but still at affordable prices - up to half the price of many other suppliers."

He continued, "I would like to extend a big thank-you to everyone who has suggested a product -- and please keep your suggestions coming -- we will continue to add them to our range!"

Contact:
Steve Roome
Commercial Director
+44 (0)1934 624 695

About Ascent Scientific:
Ascent Scientific offers a range of high quality receptor ligands and synthetic chemistry services at prices so low that as many researchers as possible will be able to afford them. The Low-Cost Ligand range includes receptor ligands and signalling tools in research areas such as glutamate, GABA, ion channels, cannabinoids, opioids, 5-HT and more.
The Low-Cost Chemistry Service provides cost-effective custom synthesis of organic molecules, fluorescent labels, standards & references, stable isotope labels, receptor ligands and more.

To request a new catalogue, visit our website http://www.ascentscientific.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

STEVE ROOME
Visit website